Definium Therapeutics, Inc. (DFTX)
17.66
+0.11
(+0.63%)
USD |
NASDAQ |
Mar 06, 16:00
17.69
+0.03
(+0.17%)
After-Hours: 20:00
Definium Therapeutics SG&A Expense (TTM) : 48.64M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Pulse Biosciences, Inc. | 32.03M |
| RxSight, Inc. | 112.65M |
| Plus Therapeutics, Inc. | 11.09M |
| Viridian Therapeutics, Inc. | 95.31M |
| Nutriband, Inc. | 7.831M |